发明名称 |
COMBINATION THERAPY FOR THE TREATMENT OF CANCER |
摘要 |
The invention relates to a method for the treatment of a cancer involving a solid tumour in a warm-blooded animal such as a human, which comprises administering to said animal an effective amount of ZD6126 or a pharmaceutically acceptable salt thereof, before, after or simultaneously with an effective amount of ZD1839 or a pharmaceutically acceptable salt thereof and before, after or simultaneously with an effective amount of ionising radiation. The invention also relates to the use of ZD6126 and ZD1839 in the manufacture of a medicament for use in the production of an anti-cancer effect in a warm-blooded animal such as a human and to pharmaceutical compositions and kits each comprising ZD6126 and ZD1839.
|
申请公布号 |
WO03088971(A1) |
申请公布日期 |
2003.10.30 |
申请号 |
WO2003GB01617 |
申请日期 |
2003.04.14 |
申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;RYAN, ANDERSON, JOSEPH |
发明人 |
RYAN, ANDERSON, JOSEPH |
分类号 |
A61K31/662;A61K31/165;A61K31/517;A61K31/5377;A61P9/10;A61P35/00;A61P43/00;(IPC1-7):A61K31/517 |
主分类号 |
A61K31/662 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|